An integrated view of cyclin E function and regulation

Cell Cycle

Volumn 11, Issue 1, 2012, Pages 57-64

  Siu, Ka Tat ^a   Rosner, Marsha Rich ^b   Minella, Alex C ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Cdk2; Cell cycle; Cyclin E; E2F; Fbw7; p21; p27; Regulatory network

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN E;

AUTOPHOSPHORYLATION; CANCER CELL; CARBOXY TERMINAL SEQUENCE; CARCINOGENICITY; CELL ACTIVITY; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL FUNCTION; ENZYME SPECIFICITY; GENE EXPRESSION REGULATION; HUMAN; MAMMAL CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REVIEW;

MAMMALIA;

EID: 84855685279     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.11.1.18775     Document Type: Review

References (108)

1. Lew DJ, Dulic V, Reed SI. Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast. Cell 1991; 66:1197-206; PMID:1833066; http://dx.doi.org/10.1016/0092-8674(91)90042-W.
2. 1 cyclins. Cell 1991; 66:1207-16; PMID:1833067; http://dx.doi.org/10.1016/0092-8674(91)90043-X.
3. Koff A, Cross F, Fisher A, Schumacher J, Leguellec K, Philippe M, et al. Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell 1991; 66:1217-28; PMID:1833068; http://dx.doi.org/10.1016/0092- 8674(91)90044-Y.
4. Hwang HC, Clurman BE. Cyclin E in normal and neoplastic cell cycles. Oncogene 2005; 24:2776-86; PMID:15838514; http://dx.doi.org/10.1038/sj.onc. 1208613.
5. Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 2005; 434:864-70; PMID:15829956; http://dx.doi.org/10.1038/nature03482.
6. Rajagopalan H, Jallepalli PV, Rago C, Velculescu VE, Kinzler KW, Vogelstein B, et al. Inactivation of hCDC4 can cause chromosomal instability. Nature 2004; 428:77-81; PMID:14999283; http://dx.doi.org/10.1038/nature02313.
7. Ekholm-Reed S, Mendez J, Tedesco D, Zetterberg A, Stillman B, Reed SI. Deregulation of cyclin E in human cells interferes with prereplication complex assembly. J Cell Biol 2004; 165:789-800; PMID:15197178; http://dx.doi.org/10. 1083/jcb.200404092.
8. Saavedra HI, Maiti B, Timmers C, Altura R, Tokuyama Y, Fukasawa K, et al. Inactivation of E2F3 results in centrosome amplification. Cancer Cell 2003; 3:333-46; PMID:12726860; http://dx.doi.org/10.1016/S1535-6108(03)00083-7.
9. Sengupta T, Abraham G, Xu Y, Clurman BE, Minella AC. Hypoxia-Inducible Factor 1 Is Activated by Dysregulated Cyclin E during Mammary Epithelial Morphogenesis. Mol Cell Biol 2011; 31:3885-95; PMID:21746877; http://dx.doi.org/10.1128/MCB.05089-11.
10. Strohmaier H, Spruck CH, Kaiser P, Won KA, Sangfelt O, Reed SI. Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature 2001; 413:316-22; PMID:11565034; http://dx.doi.org/10. 1038/35095076.
11. Moberg KH, Bell DW, Wahrer DC, Haber DA, Hariharan IK. Archipelago regulates Cyclin E levels in Drosophila and is mutated in human cancer cell lines. Nature 2001; 413:311-6; PMID:11565033; http://dx.doi.org/10.1038/ 35095068.
12. Fbw7 ubiquitin ligase. Science 2001; 294:173-7; PMID:11533444; http://dx.doi.org/10. 1126/science.1065203.
13. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, Leary RJ, et al. The genomic landscapes of human breast and colorectal cancers. Science 2007; 318:1108-13; PMID:17932254; http://dx.doi.org/10.1126/science.1145720.
14. Welcker M, Clurman BE. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer 2008; 8:83-93; PMID:18094723; http://dx.doi.org/10.1038/nrc2290.
15. Minella AC, Loeb KR, Knecht A, Welcker M, Varnum-Finney BJ, Bernstein ID, et al. Cyclin E phosphorylation regulates cell proliferation in hematopoietic and epithelial lineages in vivo. Genes Dev 2008; 22:1677-89; PMID:18559482; http://dx.doi.org/10.1101/gad.1650208.
16. Kossatz U, Breuhahn K, Wolf B, Hardtke-Wolenski M, Wilkens L, Steinemann D, et al. The cyclin E regulator cullin 3 prevents mouse hepatic progenitor cells from becoming tumor-initiating cells. J Clin Invest 2010; 120:3820-33; PMID:20978349; http://dx.doi.org/10.1172/JCI41959.
17. Ma Y, Fiering S, Black C, Liu X, Yuan Z, Memoli VA, et al. Transgenic cyclin E triggers dysplasia and multiple pulmonary adenocarcinomas. Proc Natl Acad Sci USA 2007; 104:4089-94; PMID:17360482; http://dx.doi.org/10.1073/pnas. 0606537104.
18. Smith AP, Henze M, Lee JA, Osborn KG, Keck JM, Tedesco D, et al. Deregulated cyclin E promotes p53 loss of heterozygosity and tumorigenesis in the mouse mammary gland. Oncogene 2006; 25:7245-59; PMID:16751806; http://dx.doi.org/10.1038/sj.onc.1209713.
19. Loeb KR, Kostner H, Firpo E, Norwood T, D Tsuchiya K, Clurman BE, et al. A mouse model for cyclin E-dependent genetic instability and tumorigenesis. Cancer Cell 2005; 8:35-47; PMID:16023597; http://dx.doi.org/10.1016/j.ccr.2005. 06.010.
20. Akli S, Van Pelt CS, Bui T, Multani AS, Chang S, Johnson D, et al. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway. Cancer Res 2007; 67:7212-22; PMID:17671189; http://dx.doi.org/10.1158/0008-5472. CAN-07-0599.
21. Singer JD, Gurian-West M, Clurman B, Roberts JM. Cullin-3 targets cyclin E for ubiquitination and controls S phase in mammalian cells. Genes Dev 1999; 13:2375-87; PMID:10500095; http://dx.doi.org/10.1101/gad.13.18.2375.
22. Clurman BE, Sheaff RJ, Thress K, Groudine M, Roberts JM. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev 1996; 10:1979-90; PMID:8769642; http://dx.doi.org/10.1101/gad.10.16.1979.
23. Grim JE, Gustafson MP, Hirata RK, Hagar AC, Swanger J, Welcker M, et al. Isoform- and cell cycle-dependent substrate degradation by the Fbw7 ubiquitin ligase. J Cell Biol 2008; 181:913-20; PMID:18559665; http://dx.doi.org/10.1083/ jcb.200802076.
24. Chi Y, Welcker M, Hizli AA, Posakony JJ, Aebersold R, Clurman BE. Identification of CDK2 substrates in human cell lysates. Genome Biol 2008; 9:149; PMID:18847512; http://dx.doi.org/10.1186/gb-2008-9-10-r149.
25. Blethrow JD, Glavy JS, Morgan DO, Shokat KM. Covalent capture of kinase-specific phosphopeptides reveals Cdk1-cyclin B substrates. Proc Natl Acad Sci USA 2008; 105:1442-7; PMID:18234856; http://dx.doi.org/10.1073/pnas. 0708966105.
26. Satyanarayana A, Kaldis P. Mammalian cell cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms. Oncogene 2009; 28:2925-39; PMID:19561645; http://dx.doi.org/10.1038/onc.2009.170.
27. Lees E, Faha B, Dulic V, Reed SI, Harlow E. Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev 1992; 6:1874-85; PMID:1398067; http://dx.doi.org/10.1101/gad.6.10. 1874.
28. Kõivomägi M, Valk E, Venta R, Iofik A, Lepiku M, Morgan DO, et al. Dynamics of Cdk1 substrate specificity during the cell cycle. Mol Cell 2011; 42:610-23; PMID:21658602; http://dx.doi.org/10.1016/j.molcel.2011.05.016.
29. Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 1992; 70:993-1006; PMID:1388095; http://dx.doi.org/10.1016/0092- 8674(92)90249-C.
30. 1/S-regulatory genes. Mol Cell Biol 1995; 15:4215-24; PMID:7623816.
31. Chellappan SP, Hiebert S, Mudryj M, Horowitz JM, Nevins JR. The E2F transcription factor is a cellular target for the RB protein. Cell 1991; 65:1053-61; PMID:1828392; http://dx.doi.org/10.1016/0092-8674(91)90557-F.
32. Cip1 in S phase. J Biol Chem 2003; 278:25752-7; PMID:12730199; http://dx.doi.org/10.1074/jbc.M301774200.
33. Kip1. Genes Dev 1997; 11:1464-78; PMID:9192873; http://dx.doi.org/10.1101/gad.11.11.1464.
34. 1 and S phase. Nature 2001; 413:323-7; PMID:11565035; http://dx.doi.org/10.1038/35095083.
35. Tsvetkov LM, Yeh KH, Lee SJ, Sun H, Zhang H. p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr Biol 1999; 9:661-4; PMID:10375532; http://dx.doi.org/10.1016/ S0960-9822(99)80290-5.
36. Carrano AC, Eytan E, Hershko A, Pagano M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1999; 1:193-9; PMID:10559916; http://dx.doi.org/10.1038/12013.
37. Matsuura I, Denissova NG, Wang G, He D, Long J, Liu F. Cyclin-dependent kinases regulate the antiproliferative function of Smads. Nature 2004; 430:226-31; PMID:15241418; http://dx.doi.org/10.1038/nature02650.
38. Cooley A, Zelivianski S, Jeruss JS. Impact of cyclin E overexpression on Smad3 activity in breast cancer cell lines. Cell Cycle 2010; 9:4900-7; PMID:21150326; http://dx.doi.org/10.4161/cc.9.24.14158.
39. Derynck R, Akhurst RJ, Balmain A. TGFbeta signaling in tumor suppression and cancer progression. Nat Genet 2001; 29:117-29; PMID:11586292; http://dx.doi.org/10.1038/ng1001-117.
40. Massagué J, Blain SW, Lo RS. TGFbeta signaling in growth control, cancer and heritable disorders. Cell 2000; 103:295-309; PMID:11057902; http://dx.doi.org/10.1016/S0092-8674(00)00121-5.
41. Morris L, Allen KE, La Thangue NB. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators. Nat Cell Biol 2000; 2:232-9; PMID:10783242; http://dx.doi.org/10.1038/35041123.
42. Ait-Si-Ali S, Ramirez S, Barre FX, Dkhissi F, Magnaghi-Jaulin L, Girault JA, et al. Histone acetyltransferase activity of CBP is controlled by cycledependent kinases and oncoprotein E1A. Nature 1998; 396:184-6; PMID:9823900; http://dx.doi.org/10.1038/24190.
43. Zhao J, Kennedy BK, Lawrence BD, Barbie DA, Matera AG, Fletcher JA, et al. NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription. Genes Dev 2000; 14:2283-97; PMID:10995386; http://dx.doi.org/10.1101/gad.827700.
44. Ma T, Van Tine BA, Wei Y, Garrett MD, Nelson D, Adams PD, et al. Cell cycle-regulated phosphorylation of p220(NPAT) by cyclin E/Cdk2 in Cajal bodies promotes histone gene transcription. Genes Dev 2000; 14:2298-313; PMID:10995387; http://dx.doi.org/10.1101/gad.829500.
45. Parisi T, Beck AR, Rougier N, McNeil T, Lucian L, Werb Z, et al. Cyclins E1 and E2 are required for endoreplication in placental trophoblast giant cells. EMBO J 2003; 22:4794-803; PMID:12970191; http://dx.doi.org/10.1093/emboj/ cdg482.
46. Geng Y, Yu Q, Sicinska E, Das M, Schneider JE, Bhattacharya S, et al. Cyclin E ablation in the mouse. Cell 2003; 114:431-43; PMID:12941272; http://dx.doi.org/10.1016/S0092-8674(03)00645-7.
47. Geng Y, Lee YM, Welcker M, Swanger J, Zagozdzon A, Winer JD, et al. Kinase-independent function of cyclin E. Mol Cell 2007; 25:127-39; PMID:17218276; http://dx.doi.org/10.1016/j.molcel.2006.11.029.
48. Chuang LC, Teixeira LK, Wohlschlegel JA, Henze M, Yates JR, Mendez J, et al. Phosphorylation of Mcm2 by Cdc7 promotes pre-replication complex assembly during cell cycle re-entry. Mol Cell 2009; 35:206-16; PMID:19647517; http://dx.doi.org/10.1016/j.molcel.2009.06.014.
49. Mailand N, Diffley JF. CDKs promote DNA replication origin licensing in human cells by protecting Cdc6 from APC/C-dependent proteolysis. Cell 2005; 122:915-26; PMID:16153703; http://dx.doi.org/10.1016/j.cell.2005.08.013.
50. Lunn CL, Chrivia JC, Baldassare JJ. Activation of Cdk2/Cyclin E complexes is dependent on the origin of replication licensing factor Cdc6 in mammalian cells. Cell Cycle 2010; 9:4533-41; PMID:21088490; http://dx.doi.org/10.4161/cc. 9.22.13789.
51. Tokuyama Y, Horn HF, Kawamura K, Tarapore P, Fukasawa K. Specific phosphorylation of nucleophosmin on Thr(199) by cyclin-dependent kinase 2-cyclin E and its role in centrosome duplication. J Biol Chem 2001; 276:21529-37; PMID:11278991; http://dx.doi.org/10.1074/jbc.M100014200.
52. Okuda M, Horn HF, Tarapore P, Tokuyama Y, Smulian AG, Chan PK, et al. Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication. Cell 2000; 103:127-40; PMID:11051553; http://dx.doi.org/10.1016/S0092-8674(00)00093- 3.
53. Chen Z, Indjeian VB, McManus M, Wang L, Dynlacht BD. CP110, a cell cycle-dependent CDK substrate, regulates centrosome duplication in human cells. Dev Cell 2002; 3:339-50; PMID:12361598; http://dx.doi.org/10.1016/S1534-5807(02) 00258-7.
54. Matsumoto Y, Maller JL. A centrosomal localization signal in cyclin E required for Cdk2-independent S phase entry. Science 2004; 306:885-8; PMID:15514162; http://dx.doi.org/10.1126/science.1103544.
55. Pascreau G, Churchill ME, Maller JL. Centrosomal localization of cyclins E and A: structural similarities and functional differences. Cell Cycle 2011; 10:199-205; PMID:21217199; http://dx.doi.org/10.4161/cc.10.2.14444.
56. Hydbring P, Bahram F, Su Y, Tronnersjo S, Hogstrand K, von der Lehr N, et al. Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation. Proc Natl Acad Sci USA 2010; 107:58-63; PMID:19966300; http://dx.doi.org/10.1073/pnas.0900121106.
57. Campaner S, Doni M, Hydbring P, Verrecchia A, Bianchi L, Sardella D, et al. Cdk2 suppresses cellular senescence induced by the c-myc oncogene. Nat Cell Biol 2010; 12:54-9.
58. Yada M, Hatakeyama S, Kamura T, Nishiyama M, Tsunematsu R, Imaki H, et al. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J 2004; 23:2116-25; PMID:15103331; http://dx.doi.org/10.1038/ sj.emboj.7600217.
59. Welcker M, Orian A, Grim JE, Eisenman RN, Clurman BE. A nucleolar isoform of the Fbw7 ubiquitin ligase regulates c-Myc and cell size. Curr Biol 2004; 14:1852-7; PMID:15498494; http://dx.doi.org/10.1016/j.cub.2004.09.083.
60. Sears R, Nuckolls F, Haura E, Taya Y, Tamai K, Nevins JR. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev 2000; 14:2501-14; PMID:11018017; http://dx.doi.org/10.1101/gad.836800.
61. Hemann MT, Bric A, Teruya-Feldstein J, Herbst A, Nilsson JA, Cordon-Cardo C, et al. Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants. Nature 2005; 436:807-11; PMID:16094360; http://dx.doi.org/10.1038/ nature03845.
62. Gilley J, Coffer PJ, Ham J. FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons. J Cell Biol 2003; 162:613-22; PMID:12913110; http://dx.doi.org/10.1083/jcb.200303026.
63. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999; 96:857-68; PMID:10102273; http://dx.doi.org/10.1016/S0092-8674(00) 80595-4.
64. Huang H, Regan KM, Lou Z, Chen J, Tindall DJ. CDK2-dependent phosphorylation of FOXO1 as an apoptotic response to DNA damage. Science 2006; 314:294-7; PMID:17038621; http://dx.doi.org/10.1126/science.1130512.
65. Chen S, Bohrer LR, Rai AN, Pan Y, Gan L, Zhou X, et al. Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2. Nat Cell Biol 2010; 12:1108-14; PMID:20935635; http://dx.doi.org/10.1038/ncb2116.
66. Santoni-Rugiu E, Falck J, Mailand N, Bartek J, Lukas J. Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRb/E2F pathway. Mol Cell Biol 2000; 20:3497-509; PMID:10779339; http://dx.doi.org/10.1128/MCB. 20.10.3497-509.2000.
67. Geng Y, Eaton EN, Picon M, Roberts JM, Lundberg AS, Gifford A, et al. Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene 1996; 12:1173-80; PMID:8649818.
68. Cohen EE, Zhu H, Lingen MW, Martin LE, Kuo WL, Choi EA, et al. A feed-forward loop involving protein kinase Calpha and microRNAs regulates tumor cell cycle. Cancer Res 2009; 69:65-74; PMID:19117988; http://dx.doi.org/10.1158/ 0008-5472.CAN-08-0377.
69. Minella AC, Welcker M, Clurman BE. Ras activity regulates cyclin E degradation by the Fbw7 pathway. Proc Natl Acad Sci USA 2005; 102:9649-54; PMID:15980150; http://dx.doi.org/10.1073/pnas.0503677102.
70. McEvoy JD, Kossatz U, Malek N, Singer JD. Constitutive turnover of cyclin E by Cul3 maintains quiescence. Mol Cell Biol 2007; 27:3651-66; PMID:17339333; http://dx.doi.org/10.1128/MCB.00720-06.
71. Welcker M, Orian A, Jin J, Grim JE, Harper JW, Eisenman RN, et al. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation- dependent c-Myc protein degradation. Proc Natl Acad Sci USA 2004; 101:9085-90; PMID:15150404; http://dx.doi.org/10.1073/pnas.0402770101.
72. Fbw7 antagonizes apoptotic JNK signaling. Science 2004; 303:1374-8; PMID:14739463; http://dx.doi.org/10.1126/science.1092880.
73. Gupta-Rossi N, Le Bail O, Gonen H, Brou C, Logeat F, Six E, et al. Functional interaction between SEL-10, an F-box protein, and the nuclear form of activated Notch1 receptor. J Biol Chem 2001; 276:34371-8; PMID:11425854; http://dx.doi.org/10.1074/jbc.M101343200.
74. Wertz IE, Kusam S, Lam C, Okamoto T, Sandoval W, Anderson DJ, et al. Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7. Nature 2011; 471:110-4; PMID:21368834; http://dx.doi.org/10.1038/nature09779.
75. Inuzuka H, Shaik S, Onoyama I, Gao D, Tseng A, Maser RS, et al. SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction. Nature 2011; 471:104-9; PMID:21368833; http://dx.doi.org/10.1038/ nature09732.
76. Cdc4 acts antagonistically to the PGC-1alpha transcriptional coactivator by targeting it for ubiquitin-mediated proteolysis. Genes Dev 2008; 22:252-64; PMID:18198341; http://dx.doi.org/10.1101/gad.1624208.
77. Inuzuka H, Fukushima H, Shaik S, Liu P, Lau AW, Wei W. Mcl-1 ubiquitination and destruction. Oncotarget 2011; 2:239-44; PMID:21608150.
78. Ye X, Nalepa G, Welcker M, Kessler BM, Spooner E, Qin J, et al. Recognition of phosphodegron motifs in human cyclin E by the SCF(Fbw7) ubiquitin ligase. J Biol Chem 2004; 279:50110-9; PMID:15364936; http://dx.doi.org/10. 1074/jbc.M409226200.
79. Welcker M, Singer J, Loeb KR, Grim J, Bloecher A, Gurien-West M, et al. Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation. Mol Cell 2003; 12:381-92; PMID:14536078; http://dx.doi.org/10.1016/S1097-2765(03) 00287-9.
80. Won KA, Reed SI. Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E. EMBO J 1996; 15:4182-93; PMID:8861947.
81. Grinkevich VV, Nikulenkov F, Shi Y, Enge M, Bao W, Maljukova A, et al. Ablation of key oncogenic pathways by RITA-reactivated p53 is required for efficient apoptosis. Cancer Cell 2009; 15:441-53; PMID:19411072; http://dx.doi.org/10.1016/j.ccr.2009.03.021.
82. Balamurugan K, Wang JM, Tsai HH, Sharan S, Anver M, Leighty R, et al. The tumour suppressor C/EBPdelta inhibits FBXW7 expression and promotes mammary tumour metastasis. EMBO J 2010; 29:4106-17; PMID:21076392; http://dx.doi.org/10. 1038/emboj.2010.280.
83. Figueroa ME, Skrabanek L, Li Y, Jiemjit A, Fandy TE, Paietta E, et al. MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation. Blood 2009; 114:3448-58; PMID:19652201; http://dx.doi.org/10.1182/ blood-2009-01-200519.
84. Xu Y, Sengupta T, Kukreja L, Minella AC. MicroRNA-223 regulates cyclin E activity by modulating expression of F-box and WD-40 domain protein 7. J Biol Chem 2010; 285:34439-46; PMID:20826802; http://dx.doi.org/10.1074/jbc.M110. 152306.
85. Spruck C. miR-27a regulation of SCF (Fbw7) in cell division control and cancer. Cell Cycle 2011; 10:3237-6; PMID:21946522; http://dx.doi.org/10.4161/cc. 10.19.17125.
86. Lerner M, Lundgren J, Akhoondi S, Jahn A, Ng HF, Moqadam FA, et al. MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progression. Cell Cycle 2011; 10:2172-83; PMID:21597324; http://dx.doi.org/10. 4161/cc.10.13.16248.
87. Pulikkan JA, Dengler V, Peramangalam PS, Peer Zada AA, Muller-Tidow C, Bohlander SK, et al. Cell cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. Blood 2010; 115:1768-78; PMID:20029046; http://dx.doi.org/10.1182/blood-2009-08-240101.
88. Mavrakis KJ, Van Der Meulen J, Wolfe AL, Liu X, Mets E, Taghon T, et al. A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL). Nat Genet 2011; 43:673-8; PMID:21642990; http://dx.doi.org/10.1038/ng.858.
89. Hao B, Oehlmann S, Sowa ME, Harper JW, Pavletich NP. Structure of a Fbw7-Skp1-cyclin E complex: multisite-phosphorylated substrate recognition by SCF ubiquitin ligases. Mol Cell 2007; 26:131-43; PMID:17434132; http://dx.doi.org/10.1016/j.molcel.2007.02.022.
90. Welcker M, Clurman BE. Fbw7/hCDC4 dimerization regulates its substrate interactions. Cell Div 2007; 2:7; PMID:17298674; http://dx.doi.org/10.1186/1747- 1028-2-7.
91. van Drogen F, Sangfelt O, Malyukova A, Matskova L, Yeh E, Means AR, et al. Ubiquitylation of cyclin E requires the sequential function of SCF complexes containing distinct hCdc4 isoforms. Mol Cell 2006; 23:37-48; PMID:16818231; http://dx.doi.org/10.1016/j.molcel.2006.05.020.
92. Buttitta LA, Katzaroff AJ, Edgar BA. A robust cell cycle control mechanism limits E2F-induced proliferation of terminally differentiated cells in vivo. J Cell Biol 2010; 189:981-96; PMID:20548101; http://dx.doi.org/10.1083/ jcb.200910006.
93. Kip1cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature 1996; 382:325-31; PMID:8684460; http://dx.doi.org/10.1038/382325a0.
94. Hengst L, Gopfert U, Lashuel HA, Reed SI. Complete inhibition of Cdk/cyclin by one molecule of p21(Cip1). Genes Dev 1998; 12:3882-8; PMID:9869641; http://dx.doi.org/10.1101/gad.12.24.3882.
95. Minella AC, Swanger J, Bryant E, Welcker M, Hwang H, Clurman BE. p53 and p21 form an inducible barrier that protects cells against cyclin E-cdk2 deregulation. Curr Biol 2002; 12:1817-27; PMID:12419181; http://dx.doi.org/10. 1016/S0960-9822(02)01225-3.
96. Odajima J, Kalaszczynska I, Sicinski P. Cyclins A and E trigger DNA damage. Cell Cycle 2010; 9:1231-2; PMID:20404525; http://dx.doi.org/10.4161/cc. 9.7.11313.
97. Viglietto G, Motti ML, Bruni P, Melillo RM, D'Alessio A, Califano D, et al. Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. Nat Med 2002; 8:1136-44; PMID:12244303; http://dx.doi.org/10.1038/nm762.
98. Liang J, Zubovitz J, Petrocelli T, Kotchetkov R, Connor MK, Han K, et al. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med 2002; 8:1153-60; PMID:12244302; http://dx.doi.org/10.1038/nm761.
99. Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J, et al. PKB/Akt mediates cell cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Nat Med 2002; 8:1145-52; PMID:12244301; http://dx.doi.org/10.1038/nm759.
100. Kip1 mislocalization. Oncogene 2000; 19:5926-35; PMID:11127824; http://dx.doi.org/10. 1038/sj.onc.1203991.
101. Kouvaraki M, Gorgoulis VG, Rassidakis GZ, Liodis P, Markopoulos C, Gogas J, et al. High expression levels of p27 correlate with lymph node status in a subset of advanced invasive breast carcinomas: relation to E-cadherin alterations, proliferative activity and ploidy of the tumors. Cancer 2002; 94:2454-65; PMID:12015771; http://dx.doi.org/10.1002/cncr.10505.abs.
102. Kfir S, Ehrlich M, Goldshmid A, Liu X, Kloog Y, Henis YI. Pathway- and expression level-dependent effects of oncogenic N-Ras: p27(Kip1) mislocalization by the Ral-GEF pathway and Erk-mediated interference with Smad signaling. Mol Cell Biol 2005; 25:8239-50; PMID:16135812; http://dx.doi.org/10.1128/MCB.25.18. 8239-50.2005.
103. Kip1 stability, subcellular localization and tumor suppression. Genes Dev 2006; 20:47-64; PMID:16391232; http://dx.doi.org/10.1101/gad.1384406.
104. Leone G, DeGregori J, Sears R, Jakoi L, Nevins JR. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature 1997; 387:422-6; PMID:9163430; http://dx.doi.org/10.1038/387422a0.
105. Cip1/WAF1 by Akt-induced phosphorylation in HER-2/ neu-overexpressing cells. Nat Cell Biol 2001; 3:245-52; PMID:11231573; http://dx.doi.org/10.1038/35060032.
106. Besson A, Dowdy SF, Roberts JM. CDK inhibitors: cell cycle regulators and beyond. Dev Cell 2008; 14:159-69; PMID:18267085; http://dx.doi.org/10.1016/j. devcel.2008.01.013.
107. Kip1 are directly regulated by oncogenic tyrosine kinases. Cell 2007; 128:269-80; PMID:17254966; http://dx.doi.org/10.1016/j.cell.2006.11.047.
108. Chu I, Sun J, Arnaout A, Kahn H, Hanna W, Narod S, et al. p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2. Cell 2007; 128:281-94; PMID:17254967; http://dx.doi.org/10.1016/j.cell.2006.11.049.